2 recruiting, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Recruiting 2, Completed 1 |
Follow abrysvo: new trials by email Literature Review of abrysvo trials Research Report on abrysvo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy Tdap Vaccine Administration, RSV Vaccine, Saline (as a placebo) - RSV, Tdap - Tetanus, Diphtheria and Acellular Pertussis Vaccination | Phase 4 | Recruiting | Canadian Immunization Research Network | 60 | 2025-10-16 | 2026-10-22 |
| The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products Abrysvo, Beyfortus - Respiratory Syncytial Virus Infection | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 181 | 2024-09-19 | 2026-05-11 |
| Vaccine Responses in Patients With B Cell Malignancies AREXVY, ABRYSVO, PREVNAR 20, PNEUMOVAX 23 - Lymphoma | Phase 4 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 350 | 2022-09-14 | 2026-08-04 |
Diphtheria (1) · Lymphoma (1) · Respiratory Syncytial Virus Infections (1)
Canadian Immunization Research Network (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (2) · Canada (1)
Adrian U Wiestner, M.D. (1) · Bahaa Abu-Raya, M.D., PhD (1)
5UM1AI148684-04 (1)